"Bifidobacterium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rod-shaped, gram-positive, non-acid-fast, non-spore-forming, non-motile bacterium that is a genus of the family Bifidobacteriaceae, order Bifidobacteriales, class ACTINOBACTERIA. It inhabits the intestines and feces of humans as well as the human vagina.
| Descriptor ID |
D001644
|
| MeSH Number(s) |
B03.510.024.100 B03.510.460.400.400.049.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bifidobacterium".
Below are MeSH descriptors whose meaning is more specific than "Bifidobacterium".
This graph shows the total number of publications written about "Bifidobacterium" by people in this website by year, and whether "Bifidobacterium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 3 | 0 | 3 |
| 2015 | 1 | 0 | 1 |
| 2017 | 3 | 6 | 9 |
| 2018 | 4 | 8 | 12 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bifidobacterium" by people in Profiles.
-
Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J Med Case Rep. 2021 Feb 08; 15(1):60.
-
The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis. Int J Immunopathol Pharmacol. 2020 Jan-Dec; 34:2058738420961304.
-
Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis. J Nutr Biochem. 2019 04; 66:43-51.
-
Comparative analysis of the gut microbiota in distinct statin response patients in East China. J Microbiol. 2018 Dec; 56(12):886-892.
-
In vitro fermentation of raffinose by the human gut bacteria. Food Funct. 2018 Nov 14; 9(11):5824-5831.
-
Is It Time to Use Probiotics to Prevent or Treat Obesity? Nutrients. 2018 Nov 01; 10(11).
-
Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection. PLoS One. 2018; 13(9):e0204253.
-
Association of serum bilirubin in newborns affected by jaundice with gut microbiota dysbiosis. J Nutr Biochem. 2019 01; 63:54-61.
-
Bifidobacterial Dominance of the Gut in Early Life and Acquisition of Antimicrobial Resistance. mSphere. 2018 09 26; 3(5).
-
Why is there an emerging need to look for a suitable drug delivery platform in targeting and regulating microbiota? Panminerva Med. 2018 09; 60(3):136-137.